James Magee, MD
Family Medicine · Bloomington, ILNPI 1770521007
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$272
- Phathom Pharmaceuticals, Inc.$142
- Novartis$136
- Amgen$75
- Abbott$62
- AstraZeneca$60
- plus $434 from 14 others
Across 7 payments — averaging $12,197 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$85K
What the payments were for
- Food & beverage$1,182100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 3 | $272 |
| Phathom Pharmaceuticals, Inc. | 1 | $142 |
| Novartis | 5 | $136 |
| Amgen | 5 | $75 |
| Abbott | 3 | $62 |
| AstraZeneca | 3 | $60 |
| Amarin Pharma, Inc. | 3 | $59 |
| Johnson & Johnson | 4 | $56 |
| Novo Nordisk | 3 | $54 |
| Sanofi Pasteur Inc. | 3 | $41 |
| GSK | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Pfizer | 2 | $31 |
| AbbVie | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$142
- Cologuard Collection Kit$102
How this compares
$1,182 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 137 | $144,183 |
| OzempicSemaglutide | 95 | $92,872 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $30,639 |
| JardianceEmpagliflozin | 24 | $26,672 |
| XareltoRivaroxaban | 25 | $25,172 |
| JanuviaSitagliptin Phosphate | 25 | $22,855 |
| RybelsusSemaglutide | 13 | $14,156 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $10,721 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,979 |
| ZoloftSertraline Hcl | 18 | $8,461 |
| Atorvastatin Calcium | 508 | $5,911 |
| Spiriva HandihalerTiotropium Bromide | 11 | $5,556 |
| BelsomraSuvorexant | 12 | $5,303 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $4,861 |
| Levothyroxine Sodium | 354 | $4,752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $31 | $144,183137 claims |
| Novo NordiskOzempic, Rybelsus | $54 | $107,028108 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $33 | $45,10570 claims |
| Boehringer IngelheimJardiance | $18 | $26,67224 claims |
| Johnson & JohnsonXarelto | $56 | $25,17225 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $60 | $14,84031 claims |
| AbbVieSynthroid | $24 | $3,11729 claims |
| Arbor Pharmaceuticals, Inc.Edarbyclor | $31 | $2,98912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Bloomington
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.